Dynamic thiol/disulphide homeostasis before and after radical prostatectomy in patients with prostate cancer

References

• Montague JA, Butler LM, Wu AH, Genkinger JM, Koh WP, Wong AS, et al. Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Cancer Causes Control 2012;23:1635–1641.
   PubMed Web of Science ®Google Scholar
• Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, Savaser A, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin Biochem 2009;42:1228–1235.
   PubMed Web of Science ®Google Scholar
• Turk H, Celik O, Un S, Yoldas M, Isoglu CS, Karabicak M, et al. Predictive factors for biochemical recurrence in radical prostatectomy patients. Cent European J Urol 2015;68:404–409.
   PubMed Web of Science ®Google Scholar
• Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, Vazquez E. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 2007;97:1683–1689.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zheng X, Wang X. Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer. Am J Cancer Res 2015;5:2788–2798.
   PubMed Web of Science ®Google Scholar
• Minciullo PL, Inferrera A, Navarra M, Calapai G, Magno C, Gangemi S. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int 2015;94:249–254.
   PubMed Web of Science ®Google Scholar
• Comini MA. Measurement and meaning of cellular thiol:disufhide redox status. Free Radic Res 2016;50:246–271.
   PubMed Web of Science ®Google Scholar
• Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326–332.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:11211–19.
   Web of Science ®Google Scholar
• Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89:40–48.
   PubMed Web of Science ®Google Scholar
• Chaiswing L, Zhong W, Oberley TD. Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression. Free Radic Biol Med 2014;67:342–352.
   PubMed Web of Science ®Google Scholar
• Srivastava DS, Mittal RD. Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer. Indian J Clin Biochem 2005;20:162–165.
   PubMedGoogle Scholar
• Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, Guler S. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract 2015;110:166–171.
   PubMed Web of Science ®Google Scholar
• Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 2013;65:244–253.
   PubMed Web of Science ®Google Scholar
• Matteucci E, Giampietro O. Thiol signalling network with an eye to diabetes. Molecules 2010;15:8890–8903.
   PubMed Web of Science ®Google Scholar
• Go YM, Jones DP. Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med 2011;50:495–509.
   PubMed Web of Science ®Google Scholar
• Prabhu A, Sarcar B, Kahali S, Yuan Z, Johnson JJ, Adam KP, et al. Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res 2014;74:787–796.
   PubMed Web of Science ®Google Scholar
• Tetik S, Ahmad S, Alturfan AA, Fresko I, Disbudak M, Sahin Y, et al. Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. Indian J Biochem Biophys 2010;47:353–358.
   PubMed Web of Science ®Google Scholar
• Rodrigues SD, Batista GB, Ingberman M, Pecoits-Filho R, Nakao LS. Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif 2012;34:231–237.
   PubMed Web of Science ®Google Scholar
• Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med 2013;62:13–25.
   PubMed Web of Science ®Google Scholar
• Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ, Hwang TL. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 2014;19:3327–3344.
   PubMed Web of Science ®Google Scholar
• Ates I, Ozkayar N, Inan B, Yilmaz FM, Topcuoglu C, Neselioglu S, et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens 2016;10:159–166.
   PubMed Web of Science ®Google Scholar
• Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 1999;27:1208–1218.
   PubMed Web of Science ®Google Scholar
• Dursun E, Akaln FA, Genc T, Cinar N, Erel O, Yildiz BO. Oxidative stress and periodontal disease in obesity. Medicine (Baltimore) 2016;95:e3136.
   Google Scholar
• Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 2006;39:176–179.
   PubMed Web of Science ®Google Scholar
• Dogru-Abbasoglu S, Aykac-Toker G, Kocak T, Unluer E, Uysal M. Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive. J Cancer Res Clin Oncol 1999;125:402–404.
   PubMed Web of Science ®Google Scholar
• Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32:229–233.
   PubMed Web of Science ®Google Scholar
• Aryal M, Pandeya A, Gautam N, Baral N, Lamsal M, Majhi S, Chandra L, Pandit R, Das BK. Oxidative stress in benign prostate hyperplasia. Nepal Med Coll J 2007;9(4):222–4.
   PubMedGoogle Scholar
• Ramamoorthy V, Rubens M, Saxena A, Shehadeh N. Selenium and vitamin E for prostate cancer–justifications for the SELECT study. Asian Pac J Cancer Prev 2015;16:2619–2627.
   PubMedGoogle Scholar
• Allen EM, Mieyal JJ. Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal 2012;17:1748–1763.
   PubMed Web of Science ®Google Scholar
• Kato RB, Srougi V, Salvadori FA, Ayres PP, Leite KM, Srougi M. Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer. Clinics (Sao Paulo) 2008;63:759–762.
   PubMed Web of Science ®Google Scholar
• Childs S, Haroune N, Williams L, Gronow M. Determination of cellular glutathione:glutathione disulfide ratio in prostate cancer cells by high performance liquid chromatography with electrochemical detection. J Chromatogr A 2016;1437:67–73.
   PubMed Web of Science ®Google Scholar